1 Min Read
June 1 (Reuters) - Immupharma Plc:
* Top line results anticipated in Q1 2018
* FY loss for period of £5.3 million
* No dividend is proposed
* FY basic and diluted loss per share was 4.54p Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.